EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Suzetrigine: A promising analgesic targeting voltage-gated sodium channel

Samarjit Dey, M V Eeshwar, Vamshidhar Chamala, Sunit Kumar Gupta

Indian Journal of Pharmacology · 2026-05 · 58 (3) · 272-275

DOI: 10.4103/ijp.ijp_854_25 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Indian Journal of Pharmacology, online erschienen am 01.05.2026. Verfasst von Samarjit Dey und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, All India Institute of Medical Sciences, Mangalagiri, Andhra Pradesh, India. Hauptthemen laut MEDLINE: Analgesics, Voltage-Gated Sodium Channel Blockers, Voltage-Gated Sodium Channels, Sodium Channel Blockers. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic pain management continues to challenge clinicians due to limitations in efficacy and tolerability of current pharmacological therapies. Suzetrigine, a first-in-class selective sodium channel blocker, has emerged as a promising agent for the treatment of neuropathic and chronic pain syndromes. Preclinical and clinical data highlight suzetrigine’s unique sodium channel selectivity, reduced central nervous system side effects, and encouraging efficacy signals in neuropathic pain, trigeminal neuralgia, and refractory pain states. Early-phase trials report favorable safety and tolerability compared to conventional sodium channel blockers. Suzetrigine represents a promising new analgesic agent with a novel mechanism of action. Further Phase 3 studies are warranted to establish its role in pain medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnalgesicsVoltage-Gated Sodium Channel BlockersVoltage-Gated Sodium ChannelsSodium Channel BlockersChronic PainHumansAnimalsNeuralgiaAmidesAminopyridinesFurans

Stichwörter der Autor:innen

Painsodium channelsuzetrigine

Substanzen

AnalgesicsVoltage-Gated Sodium Channel BlockersVoltage-Gated Sodium ChannelsSodium Channel BlockerssuzetrigineAmidesAminopyridinesFurans

Autor:innen und Institutionen

  • Department of Anaesthesiology, All India Institute of Medical Sciences, Mangalagiri, Andhra Pradesh, India.

Zitieren

APA

Dey, S., Eeshwar, M. V., Chamala, V., & Gupta, S. K. (2026). Suzetrigine: A promising analgesic targeting voltage-gated sodium channel. Indian Journal of Pharmacology, 58(3), 272-275. https://doi.org/10.4103/ijp.ijp_854_25

Vancouver

Dey S, Eeshwar MV, Chamala V, Gupta SK. Suzetrigine: A promising analgesic targeting voltage-gated sodium channel. Indian Journal of Pharmacology. 2026;58(3):272-275. doi:10.4103/ijp.ijp_854_25

BibTeX
@article{Dey2026,
  author = {Dey, Samarjit and Eeshwar, M V and Chamala, Vamshidhar and Gupta, Sunit Kumar},
  title = {Suzetrigine: A promising analgesic targeting voltage-gated sodium channel},
  journal = {Indian Journal of Pharmacology},
  year = {2026},
  volume = {58},
  number = {3},
  pages = {272--275},
  doi = {10.4103/ijp.ijp_854_25}
}
Kostenlos starten →